O'Brien Greene & Co’s Calumet Specialty Products CLMT Stock Holding History

O'Brien Greene & Co’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$602K	Buy	+11,500	New	+$544K	0.17%	79
2024 Q3	–	Sell	-29,200	Closed	-$469K	–	138
2024 Q2	$469K	Sell	29,200 -32,500	-53%	-$513K	0.15%	88
2024 Q1	$917K	Buy	61,700 +11,700	+23%	+$186K	0.3%	58
2023 Q4	$894K	Buy	50,000 +2,000	+4%	+$32.4K	0.31%	57
2023 Q3	$917K	Buy	+48,000	New	+$831K	0.34%	52
2021 Q1	–	Sell	-33,001	Closed	-$103K	–	129
2020 Q4	$103K	Sell	33,001 -7,000	-17%	-$24.4K	0.04%	117
2020 Q3	$102K	Sell	40,001 -18,839	-32%	-$48.4K	0.05%	103
2020 Q2	$134K	Buy	+58,840	New	+$126K	0.07%	100

Other funds holding CLMT

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Hennessy Advisors Inc Novato, California $2.66B AUM 26.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

O'Brien Greene & Co's CLMT Position: Q3 2026 in Review

O'Brien Greene & Co opened a new position in Calumet Specialty Products (CLMT) in Q3 2026: 11,500 shares worth $602K. The stake represents 0.17% of the portfolio and ranks #79 among its holdings. This is a return to the name: O'Brien Greene & Co previously reported a position in CLMT as recently as Q2 2024.

O'Brien Greene & Co first reported a position in CLMT in Q2 2020 and has held it in 8 quarters since. The position peaked at $917K in Q1 2024. 81 funds tracked by Wall St. Rank hold CLMT as of Q3 2026.

O'Brien Greene & Co held 11,500 shares of Calumet Specialty Products worth $602K as of Q3 2026.
Calumet Specialty Products was a new O'Brien Greene & Co position in Q3 2026.
Calumet Specialty Products made up 0.17% of O'Brien Greene & Co's portfolio in Q3 2026, its #79 holding.
O'Brien Greene & Co first reported a position in Calumet Specialty Products in Q2 2020 and has held it in 8 quarters since.
O'Brien Greene & Co's Calumet Specialty Products position peaked at $917K in Q1 2024.
81 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2026.

Based on O'Brien Greene & Co's 13F filing for Q3 2026, filed 5 Nov 2026.